Research

  • Double MajorChemical Engineering (BS) and Chemistry (BA)AwardCollege of Engineering and Applied Science Research AwardFuture PlansPursuing a Material Science and Engineering PhD at the University of Colorado BoulderWhy were you
  • MajorChemical and Biological EngineeringAwardsCEAS Academic Engagement AwardCEAS Culture Impact AwardCEAS Research AwardPost-graduation plansResearch at the Institute of Future Fuels at the DLR (German Aerospace Center) in Cologne
  • Headshot of Professor Stephanie Bryant wearing glasses, and her lab in the background.
    Professor Stephanie Bryant is leading a $33.57 million federal grant to reverse osteoarthritis, and the New York Times is taking notice.
  • MajorChemical and Biological EngineeringAwardsOutstanding Undergraduate of the CollegeCEAS Academic Engagement AwardCEAS Research AwardWhy do you think you were selected for these awards?What is your favorite ÎÞÂëÊÓÆµ memory?
  • Stephanie Bryant, professor of chemical and biological engineering, stands beside a seated colleague in a laboratory, observing a computer screen displaying microscope images while using a microscope workstation with lab equipment and sample containers nearby.
    A ÎÞÂëÊÓÆµ-led team has developed a suite of new therapies aimed at reversing osteoarthritis in a single injection. With animal studies showing promise and funding from the Advanced Research Projects Agency for Health extended, the team could be ready for human trials by 2028. Professor Stephanie Bryant is the principal investigator of the project.
  • Kristi Anseth
    Distinguished Professor Kristi Anseth has received theÌýBiomaterials Global Impact Award, which recognizes distinguished research and development accomplishments in the field of biomaterials. Anseth is known for developing tissue substitutes that improve treatments for conditions like broken bones and heart valve disease.
  • An AI generated illustration of a liver. Adobe Stock photo
    ÎÞÂëÊÓÆµ researchers and partners at MIT, Harvard and Columbia are working to recreate the human liver’s complex structure in the lab. With support from a $25 million ARPA-H grant, the team aims to develop 3D-printed, transplantable liver tissue made from human cells that the body won’t reject. Professor Jason Burdick's lab at CU’s BioFrontiers Institute will lead the 3D printing component of the project.
  • Microscopy images comparing cell behavior in different hydrogels. Columns labeled “no cells,” “viscoelastic,” and “elastic” show green hydrogel shapes (circle, square, triangle). In viscoelastic hydrogels, purple mesenchymal stromal cells spread and deform the green matrix. In elastic hydrogels, the purple cells remain confined and clustered without spreading. Scale bar: 500 micrometers.
    A new light-controlled hydrogel developed at ÎÞÂëÊÓÆµ mimics the movement and flexibility of real tissue, giving scientists a more realistic way to study cells and disease. The work was recently published in the journal Matter and was directed by Distinguished Professor Kristi Anseth.
  • Assistant Professor Laurel Hind’s lab discovered how certain immune cells can suppress the body’s response to infection, using advanced human cell models.
  • perovskite solar cell
    Professor Michael D. McGehee and his team are advancing tandem solar cells—pairing silicon with a high-efficiency material called perovskite—that could significantly improve the economics of renewable energy. While the technology shows great promise, making perovskites durable enough for commercial use remains a key challenge. In October 2025, just as the research was gaining momentum, the Trump administration abruptly terminated the team’s federal grant.
Subscribe to Research